Skip to main content
Top
Published in: Clinical Rheumatology 8/2007

01-08-2007 | Original Article

Serum hyaluronan levels in patients with knee osteoarthritis

Authors: Yasemin Turan, Serpil Bal, Alev Gurgan, Hatice Topac, Mehmet Koseoglu

Published in: Clinical Rheumatology | Issue 8/2007

Login to get access

Abstract

We examined the association between clinical parameters of disease activity and serum hyaluronic acid (HA) level in patients with knee osteoarthritis (OA). Fifty-eight patients with knee OA and 40 healthy individuals were included in this study. Demographic data were noted. The radiological evaluation was done according to Kellgren/Lawrence Grading System. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used in evaluating the clinical disability caused by OA. Erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP) level were determined in laboratory evaluations. Serum HA levels (in nanogram per milliliter) of both groups were measured by enzyme-linked immunosorbent assay. The mean ages of patients in OA group and control group were 57.58 (9.55) and 43.3(10.2) years, respectively. There was a significant difference between HA levels of both groups (p = 0.02). Also, there was a significant correlation between HA level and disease duration (p = 0.04), ESR (p = 0.001), and CRP level (p < 0.001). However, there was no significant correlation between HA levels with WOMAC and radiological grade (p > 0.05). There is no satisfactory amount of data regarding HA level in OA. In our study, we demonstrated that HA was in high levels in the serum of patients with OA. We suggest that serum HA levels may be used as a marker to determine the disease activity.
Literature
1.
go back to reference Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM (2005) Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52:105–111PubMedCrossRef Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM (2005) Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52:105–111PubMedCrossRef
2.
go back to reference Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, Dieppe P (1995) Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760–767PubMedCrossRef Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, Dieppe P (1995) Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760–767PubMedCrossRef
3.
go back to reference Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953–968PubMedCrossRef Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953–968PubMedCrossRef
4.
go back to reference Wells AF, Klareskog L, Lindblad S, Laurent TC (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum 35:391–396PubMedCrossRef Wells AF, Klareskog L, Lindblad S, Laurent TC (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum 35:391–396PubMedCrossRef
5.
go back to reference Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, Granath KA, Laurent C, Laurent UB, Lilja K et al (1986) The catabolic fate of hyaluronic acid. Connect Tissue Res 15:33–41PubMed Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, Granath KA, Laurent C, Laurent UB, Lilja K et al (1986) The catabolic fate of hyaluronic acid. Connect Tissue Res 15:33–41PubMed
6.
go back to reference Hallgren R, Engstrom-Laurent A, Nisbeth U (1987) Circulating hyaluronate: a potential marker of altered metabolism of the connective tissue in uremia. Nephron 46:150–154PubMedCrossRef Hallgren R, Engstrom-Laurent A, Nisbeth U (1987) Circulating hyaluronate: a potential marker of altered metabolism of the connective tissue in uremia. Nephron 46:150–154PubMedCrossRef
7.
go back to reference Wilkinson CR, Bower LM, Warren C (1996) The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 256:165–173PubMedCrossRef Wilkinson CR, Bower LM, Warren C (1996) The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 256:165–173PubMedCrossRef
8.
go back to reference Manley G, Warren C (1987) Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987 40:626–630CrossRef Manley G, Warren C (1987) Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987 40:626–630CrossRef
9.
go back to reference Faber J, Horslev-Petersen K, Perrild H, Lorenzen I (1990) Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab 71:1016–1021PubMedCrossRef Faber J, Horslev-Petersen K, Perrild H, Lorenzen I (1990) Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab 71:1016–1021PubMedCrossRef
10.
go back to reference Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K (1992) Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61:187–191PubMed Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K (1992) Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61:187–191PubMed
11.
go back to reference Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83–88PubMedCrossRef Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83–88PubMedCrossRef
12.
go back to reference Lundin A, Engstrom-Laurent A, Hallgren R, Michaelsson G (1985) Circulating hyaluronate in psoriasis. Br J Dermatol 112:663–671PubMedCrossRef Lundin A, Engstrom-Laurent A, Hallgren R, Michaelsson G (1985) Circulating hyaluronate in psoriasis. Br J Dermatol 112:663–671PubMedCrossRef
13.
go back to reference Nishida Y, D’Souza AL, Thonar EJM, Knudson W (2000) Stimulation of hyaluronan metabolism by interleukin 1α in human articular cartilage. Arthritis Rheum 43:1315–1326PubMedCrossRef Nishida Y, D’Souza AL, Thonar EJM, Knudson W (2000) Stimulation of hyaluronan metabolism by interleukin 1α in human articular cartilage. Arthritis Rheum 43:1315–1326PubMedCrossRef
14.
go back to reference Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(Suppl 27):19–23 Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(Suppl 27):19–23
15.
go back to reference Kellgren JH, Lawrence JS (eds) (1963) The epidemiology of chronic rheumatism, atlas of standard radiographs. Blackwell, Oxford, UK Kellgren JH, Lawrence JS (eds) (1963) The epidemiology of chronic rheumatism, atlas of standard radiographs. Blackwell, Oxford, UK
16.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L (1988) Validation study of WOMAC: a health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1:95–108 Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L (1988) Validation study of WOMAC: a health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1:95–108
17.
go back to reference Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 278:9808–9812PubMedCrossRef Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 278:9808–9812PubMedCrossRef
18.
go back to reference Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M (1990) Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 33:790–799PubMedCrossRef Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M (1990) Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 33:790–799PubMedCrossRef
19.
go back to reference Manicourt DH, Triki R, Fukuda K, Devogelaer JP, de Deuxchasnes CN, Thonar EJ (1993) Levels of circulating tumor necrosis factor and interleukin-6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36:490–499PubMedCrossRef Manicourt DH, Triki R, Fukuda K, Devogelaer JP, de Deuxchasnes CN, Thonar EJ (1993) Levels of circulating tumor necrosis factor and interleukin-6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36:490–499PubMedCrossRef
20.
go back to reference Hedin PJ, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease: lack of association. J Rheumatol 18:1601–1605PubMed Hedin PJ, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease: lack of association. J Rheumatol 18:1601–1605PubMed
21.
go back to reference Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 23:974–978PubMed Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 23:974–978PubMed
22.
go back to reference Sharma L, Hurwitz DE, Thonar EJ, Sum JA, Lenz ME, Dunlop DD, Schnitzer TJ, Kirwan-Mellis G, Andriacchi TP (1998) Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis Rheum 41(7):1233–1240PubMedCrossRef Sharma L, Hurwitz DE, Thonar EJ, Sum JA, Lenz ME, Dunlop DD, Schnitzer TJ, Kirwan-Mellis G, Andriacchi TP (1998) Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis Rheum 41(7):1233–1240PubMedCrossRef
23.
go back to reference Thonar EJ, Masuda K, Lenz ME, Hauselmann HJ, Kuettner KE, Manicourt DH (1995) Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 43:68–70PubMed Thonar EJ, Masuda K, Lenz ME, Hauselmann HJ, Kuettner KE, Manicourt DH (1995) Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 43:68–70PubMed
24.
go back to reference Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799–807PubMedCrossRef Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799–807PubMedCrossRef
25.
go back to reference Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601PubMedCrossRef Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601PubMedCrossRef
26.
go back to reference Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40:723–727PubMedCrossRef Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40:723–727PubMedCrossRef
27.
go back to reference Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988) Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicillamine, or azothioprine. Ann Rheum Dis 47:116–126PubMed Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988) Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicillamine, or azothioprine. Ann Rheum Dis 47:116–126PubMed
28.
go back to reference Levesque H, Delpech B, Le Loet X, Deshayes P (1988) Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 27:445–449PubMedCrossRef Levesque H, Delpech B, Le Loet X, Deshayes P (1988) Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 27:445–449PubMedCrossRef
29.
go back to reference Di Cesare PE, Abramson SB (2005) Pathogenesis of osteoarthritis. In: Harris ED (ed) Kelley’s textbook of rheumatology, 7th edn. Elsevier, Philadelphia, PA, pp 1493–1513 Di Cesare PE, Abramson SB (2005) Pathogenesis of osteoarthritis. In: Harris ED (ed) Kelley’s textbook of rheumatology, 7th edn. Elsevier, Philadelphia, PA, pp 1493–1513
Metadata
Title
Serum hyaluronan levels in patients with knee osteoarthritis
Authors
Yasemin Turan
Serpil Bal
Alev Gurgan
Hatice Topac
Mehmet Koseoglu
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0499-4

Other articles of this Issue 8/2007

Clinical Rheumatology 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.